Penny Pinnock, Siemens Financial Services, explores how more efficient and accurate technology is contributing to improved healthcare outcomes and helping private hospital groups cope with supporting NHS backlog.
In our latest EPM Online Insight, Andy Clarke, Country Manager (UK), at YSDS explores the complexities and demands of low volume, high value shipments through specialist logistics support.
Bryan Hill (Global / Americas), Gaga Syal (GGM) & Rohit Alimchandani (UK) - Cognizant discuss how life sciences organisations should prepare for the quantum revolution in our latest EPM Online Insights.
Jimin Kim, Senior CDO Business Strategist at Samsung Biologics, lays out the challenges of successfully progressing complex biologics from clinic to commercialisation.
In our latest EPM Online Insight, ACG's Subhashis Chakraborty and Shincy Jacob attempt to answer what groundbreaking innovations lie ahead for capsules, and how will these developments redefine their role in the evolving landscape of drug delivery?
EPM Editor Jai McIntosh recently caught up with Campbell Bunce, Chief Scientific Officer and Cambridge Site Head at Abzena to discuss Abzena’s ThioBridge technology.
Niklas Adamsson, COO at Envirotainer explores the key trends set to shape the pharmaceutical cold chain in 2024 – a sector that carries an immense responsibility with lives depending on its success.
Nicholas Panico, Scientific and Regulatory Affairs Specialist at Symbio Proinnovera explores Eczema and Our Evolving Environment in our latest EPM Online Insight.
Joseph Boyd, PhD., and Vi Chu, Ph.D., Cell Biology R&D, Life Science Business of Merck explore the challenges and solutions of organoids in cancer research.
In this article, Jeff Livick, Director of Business Development at Sharp Services will explore the trends from 2023, how they will shape the industry in the coming year, and predictions for 2024.
We caught up with LogiPharma's Will Robinson to discuss one of their recent sustainability reports, supply chains, and what the pharma world needs to prioritise throughout 2024.
